http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611375-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d87a87dfbdb29b17d6d43d5f25bf944d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 |
| filingDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_821ffab123fa4b901d480b727e42aa24 |
| publicationDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2611375-C1 |
| titleOfInvention | Method for restoring uterus functions, impaired in case of acute or chronic inflammation |
| abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention relates to field of medicine and deals with field of gynecology. Prescribed are: desensitising therapy, antibacterial therapy taking into account microbial factor, which is selected depending on type of pthogen and sensitivity to antibacterial medications and/or with prescription of anti-inflammatory therapy, as well as if necessary infusion-transfusion therapy, immune-correcting therapy, systemic enzyme therapy or hormonal therapy, on condition that Laennec is introduced intravenously by drop introduction in dose 8-10.0 ml of medication, diluted with 250 ml of physiological solution (0.9% sodium chloride solution) or 5% glucose solution, for 1 hour 30 minutes or 1 hour 20 minutes 2 times per week with course of 10 procedures, with the following introduction of Laennec in dose 6.0 ml 1-2 times per month in I phase of cycle intravenously by drop introduction or intramuscularly for 4-6 month. n EFFECT: application of medication Laennec is claimed in complex therapy of recovery of uterus functions, impaired in case of acute and chronic inflammation. n 2 cl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2655538-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2709229-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2792572-C1 |
| priorityDate | 2016-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.